1986
DOI: 10.1001/archinte.1986.00360220169028
|View full text |Cite
|
Sign up to set email alerts
|

Renal Interstitial Fibrosis and Vascular Changes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1990
1990
2022
2022

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 47 publications
(2 citation statements)
references
References 13 publications
0
2
0
Order By: Relevance
“…Svenson et al 12 did not consider arteriolopathy to be a major pathogenic factor inducing interstitial fibrosis, because focal interstitial fibrosis was observed without apparent arteriolar hyalinosis. In our patient, arteriolar hyalinosis was mild, and arteriolosclerosis was not found, so the contribution of hemodynamic factors to focal fibrosis could be ruled out in this patient.…”
Section: Discussionmentioning
confidence: 99%
“…Svenson et al 12 did not consider arteriolopathy to be a major pathogenic factor inducing interstitial fibrosis, because focal interstitial fibrosis was observed without apparent arteriolar hyalinosis. In our patient, arteriolar hyalinosis was mild, and arteriolosclerosis was not found, so the contribution of hemodynamic factors to focal fibrosis could be ruled out in this patient.…”
Section: Discussionmentioning
confidence: 99%
“…Methotrexate is also administered as an adjunct therapy, more so for patients who can't tolerate the side effects of high dose steroid therapy [39,40]. Other adjunctive therapeutic medications used in conjunction with steroids are Azathioprine, cyclophosphamide, Cyclosporin A, antiCD4 monoclonal antibodies and dapsone [41][42][43][44][45][46][47].…”
Section: Treatmentmentioning
confidence: 99%